Scholar Rock
Details
-
Unternehmenstyp
Globaler Konzern
About Scholar Rock
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company is recognized as a global leader in myostatin biology, which involves proteins that regulate muscle mass. Scholar Rock is dedicated to unlocking fundamentally different treatment approaches through its proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.
Career Opportunities
Scholar Rock offers exciting opportunities for professionals looking to make a significant impact in the biopharmaceutical industry. The company fosters a collaborative and innovative working environment, encouraging employees to contribute to groundbreaking advancements in patient care.
- Opportunity to work on cutting-edge therapies
- Collaborative and innovative work culture
- Focus on professional development and growth